Go to deals
Healthcare

Investmed Holdings Pty Limited has acquired 25% of Presmed Australia

Advanced Health Limited has sold 25% of its shares in Presmed Australia to Investmed Holdings Pty Limited.

Presmed Australia is the owner and operator of four day hospitals in Australia. Founded in 1997, it is one of the leading healthcare companies in Australia that specializes in the establishment and management of surgical day hospitals.

Investmed Holdings is an investment company formed by the management of Presmed Australia.

Advanced Health establishes, invests in and manages day hospitals. Its facilities are modern, compact and equipped to render same-day surgical procedures.

Oaklins’ team in South Africa acted as designated advisor to Advanced Health Limited.

Parties

Talk to the deal team

Annerie Britz

Senior Associate
Johannesburg, South Africa
Oaklins African Bank

Jean De Wet

Associate Director
Johannesburg, South Africa
Oaklins African Bank

Related deals

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Afric Phar has been acquired by Pharma Capital
Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more